Steward Partners Investment Advisory LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.0% in the 4th quarter, HoldingsChannel reports. The firm owned 67,382 shares of the financial services provider’s stock after buying an additional 1,328 shares during the period. Steward Partners Investment Advisory LLC’s holdings in CME Group were worth $15,648,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Truvestments Capital LLC acquired a new position in shares of CME Group in the third quarter valued at approximately $26,000. SJS Investment Consulting Inc. boosted its stake in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares during the period. Dunhill Financial LLC grew its holdings in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after buying an additional 81 shares in the last quarter. Financial Life Planners bought a new position in CME Group during the 4th quarter worth $32,000. Finally, Fortitude Family Office LLC lifted its holdings in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after buying an additional 83 shares in the last quarter. 87.75% of the stock is owned by institutional investors.
Analysts Set New Price Targets
CME has been the topic of several research reports. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and decreased their price target for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Piper Sandler increased their target price on shares of CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Barclays raised their target price on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Keefe, Bruyette & Woods boosted their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research note on Friday, February 14th. Finally, Oppenheimer raised their price objective on CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $236.13.
CME Group Price Performance
CME stock opened at $251.98 on Wednesday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $258.78. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a market cap of $90.80 billion, a price-to-earnings ratio of 26.06, a P/E/G ratio of 6.76 and a beta of 0.57. The company has a 50 day simple moving average of $239.05 and a 200 day simple moving average of $229.89.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group announced that its Board of Directors has approved a stock buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
CME Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be given a $1.25 dividend. The ex-dividend date of this dividend is Friday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.98%. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
Insider Activity
In other news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,076 shares of company stock valued at $4,271,496. 0.30% of the stock is currently owned by corporate insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Technology Stocks Explained: Here’s What to Know About Tech
- GitLab: Get In While It’s Down—Big Rebound Ahead
- Best Stocks Under $5.00
- Tesla Stock: Finding a Bottom May Take Time
- EV Stocks and How to Profit from Them
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.